Literature DB >> 15246938

Leukomelanoderma following acute cutaneous graft-versus-host disease.

Hee Young Kang1, Won Hyoung Kang.   

Abstract

Acute graft versus host disease (GVHD) is characterized by a selective epithelial inflammation that can affect the skin, digestive tract, and liver. Development of pigmentary abnormalities can be observed in sites where acute cutaneous GVHD has occurred, and usually consists of hyperpigmented spots. We observed atypical pigmetary changes consisting of a combination of hyper- and hypopigmentation, so called leukomelanoderma, in a young allogeneic bone marrow recipient who suffered repetitive acute GVHD. The histopathological examinations showed features of a post-inflammatory process. Because keratinocytes produce inflammatory cytokines including tumor necrosis factor (TNF)-alpha and interleukin (IL)-1alpha, which may be implicated in the inflammatory phenomena seen in acute GVHD, we studied whether these inflammatory cytokines might be implicated in these pigmentary changes. The cytokines tested were IL-1alpha, IL-2, TNF-alpha and IL-10. The expression of TNF-alpha increased in the hyperpigmented skin relative to normal and hypopigmented skin. While TNF-alpha was variably distributed in proportion to different degrees of pigmentation, other molecules were detected at minimal levels in all samples. This observation may indicate that the production of TNF-alpha by epidermal microenvironment may be involved in postinflammatory pigmentary changes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15246938

Source DB:  PubMed          Journal:  Eur J Dermatol        ISSN: 1167-1122            Impact factor:   3.328


  2 in total

Review 1.  Vitiligo following stem-cell transplant.

Authors:  Alessio Totani; Hossam Amin; Stephen Bacchi; Ian Lewis
Journal:  Bone Marrow Transplant       Date:  2019-07-29       Impact factor: 5.483

2.  SFRP4 Expression Is Linked to Immune-Driven Fibrotic Conditions, Correlates with Skin and Lung Fibrosis in SSc and a Potential EMT Biomarker.

Authors:  Ilaria Tinazzi; Panji Mulipa; Chiara Colato; Giuseppina Abignano; Andrea Ballarin; Domenico Biasi; Paul Emery; Rebecca L Ross; Francesco Del Galdo
Journal:  J Clin Med       Date:  2021-12-13       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.